Bioventus Inc.
BVS · NASDAQ
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,155 | $9,272 | -$3,322 | -$318 |
| Dep. & Amort. | $11,403 | $12,049 | $11,865 | $12,405 |
| Deferred Tax | $135 | $44 | $43 | $3,215 |
| Stock-Based Comp. | $0 | $3,643 | $2,414 | $1,731 |
| Change in WC | $10,677 | $477 | -$31,201 | -$2,108 |
| Other Non-Cash | $4,728 | $453 | $870 | $4,397 |
| Operating Cash Flow | $30,098 | $25,938 | -$19,331 | $19,322 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$473 | -$683 | -$826 | -$574 |
| Net Acquisitions | $0 | $0 | $0 | $24,678 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$686 | $0 | $0 |
| Investing Cash Flow | -$473 | -$1,369 | -$826 | $24,104 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$19,857 | -$5,000 | $10,000 | -$48,264 |
| Stock Issued | $96 | $1,317 | $150 | $1,103 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$216 | -$10,980 | -$9,203 | $4,306 |
| Financing Cash Flow | -$19,977 | -$14,663 | $947 | -$42,855 |
| Forex Effect | -$394 | $202 | $430 | -$2,063 |
| Net Chg. in Cash | $9,254 | $10,108 | -$18,780 | -$1,492 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $32,910 | $22,802 | $41,582 | $43,074 |
| End Cash | $42,164 | $32,910 | $22,802 | $41,582 |
| Free Cash Flow | $29,625 | $25,255 | -$20,157 | $18,748 |